International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors
Tóm tắt
Từ khóa
Tài liệu tham khảo
Arnis, 1994, A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin, J Biol Chem, 269, 23879, 10.1016/S0021-9258(19)51020-1
Balík, 2004, Melatonin action in neonatal gonadotrophs, Physiol Res, 53, S153, 10.33549/physiolres.930000.53.S153
Baldwin, 1993, The probable arrangement of the helices in G protein-coupled receptors, EMBO J, 12, 1693, 10.1002/j.1460-2075.1993.tb05814.x
Ballesteros JA Weinstein H (1995) Integrated Methods for the Construction of Three-Dimensional Models and Computational Probing of Structure-Function Relations in G Protein-Coupled Receptors, in Methods in Neuroscience: Receptor Molecular Biology ( Sealfon SC ed) pp 366–428, Academic Press, San Diego.
Barrenetxe, 2004, Physiological and metabolic functions of melatonin, J Physiol Biochem, 60, 61, 10.1007/BF03168221
Barrett, 1997, Cloning and functional analysis of a polymorphic variant of the ovine Mel 1a melatonin receptor, Biochim Biophys Acta, 1356, 299, 10.1016/S0167-4889(96)00179-6
Beresford, 1998, GR196429: a nonindolic agonist at high-affinity melatonin receptors, J Pharmacol Exp Ther, 285, 1239
Bordt, 2001, N1E-115 mouse neuroblastoma cells express MT1 melatonin receptors and produce neurites in response to melatonin, Biochim Biophys Acta, 1499, 257, 10.1016/S0167-4889(00)00127-0
Cajochen, 2005, TAK-375 Takeda, Curr Opin Investig Drugs, 6, 114
Cajochen, 1997, Melatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostasis, Am J Physiol, 272, R1189
Cardinali, 1997, Melatonin site and mechanism of action: single or multiple?, J Pineal Res, 23, 32, 10.1111/j.1600-079X.1997.tb00332.x
Clemens, 1986, Development of drugs to modify the actions of melatonin, J Neural Transm Suppl, 21, 451
Dauchy, 2003, Physiologic melatonin concentration, omega-3 fatty acids, and conjugated linoleic acid inhibit fatty acid transport in rodent hind limb skeletal muscle in vivo, Comp Med, 53, 186
Drazen, 2001, Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist, Am J Physiol Regul Integr Comp Physiol, 280, R1476, 10.1152/ajpregu.2001.280.5.R1476
Dubocovich, 1985, Characterization of a retinal melatonin receptor, J Pharmacol Exp Ther, 234, 395
Dubocovich, 1988, Luzindole (N-0774): a novel melatonin receptor antagonist, J Pharmacol Exp Ther, 246, 902
Dubocovich, 1988, Pharmacology and function of melatonin receptors, FASEB J, 2, 2765, 10.1096/fasebj.2.12.2842214
Dubocovich ML (1988c) Pharmacology and function of melatonin in retina, in Progress in Retinal Research ( Osborne NN Chader G eds) pp 129–151, Pergamon Press, Oxford.
Dubocovich, 2006, Agomelatine targets a range of major depressive disorder symptoms, Curr Opin Investig Drugs, 7, 670
Dubocovich, 2007, Melatonin receptors: role on sleep and circadian rhythm regulation, Sleep Med, 8, 34, 10.1016/j.sleep.2007.10.007
Dubocovich ML Cardinali DP Delagrange P Krause DN Strosberg AD Sugden D Yocca FD (2000) Melatonin receptors, in The IUPHAR Compendium of Receptor Characterization and Classification, 2nd ed ( Girdlestone D ed) pp 270–277, IUPHAR Media, London.
Dubocovich ML Cardinali DP Guardiola-Lemaitre B Hagan RM Krause DN Sugden D Vanhoutte PM Yocca FD (1998a) Melatonin receptors, in The IUPHAR Compendium of Receptor Characterization and Classification pp 187–193, IUPHAR Media, London.
Dubocovich ML Delagrange P Olcese J (2009) Melatonin receptors, in IUPHAR database (IUPHAR-DB). Available at: http://www.iuphar-db.org/DATABASE/FamilyMenuForward?familyId=39 .
Dubocovich, 2005, Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse, J Pineal Res, 39, 113, 10.1111/j.1600-079X.2005.00230.x
Dubocovich ML Masana M (2003) Melatonin receptor signaling, in Encyclopedia of Hormones and Related Cell Regulators ( Henry H Norman A eds), pp 638–644, Academic Press, San Diego, CA.
Dubocovich ML Masana MI (1998) The efficacy of melatonin receptor analogues is dependent on the level of human melatonin receptor subtype expression, in Biological Clocks Mechanisms and Applications ( Touitou Y ed) pp 289–293, Elsevier Science, Amsterdam.
Dubocovich, 1999, 3H-4P-PDOT: A selective MT2 melatonin (MLT) receptor antagonist radioligand, Soc Neurosci Abstr, 25, 351
Dubocovich, 1998, Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms, FASEB J, 12, 1211, 10.1096/fasebj.12.12.1211
Eison, 1993, Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells, Life Sci, 53, L393, 10.1016/0024-3205(93)90494-N
Evans, 1992, Evidence for direct vasoconstrictor activity of melatonin in “pressurized” segments of isolated caudal artery from juvenile rats, Naunyn Schmiedebergs Arch Pharmacol, 346, 362, 10.1007/BF00173553
Ferguson, 2001, Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling, Pharmacol Rev, 53, 1
Geary, 1997, Melatonin directly constricts rat cerebral arteries through modulation of potassium channels, Am J Physiol, 273, H1530
Glaser, 1998, Selective MT2 melatonin receptor antagonists are inverse agonists on human mt1 melatonin receptor, FASEB J, 12, 894
Guilleminault, 2005, P. 2.064 Efficacy of agomelatine versus venlafaxine on subjective sleep of patients with major depressive disorder, J Eur Coll Neuropsychophamacol, 15, S419, 10.1016/S0924-977X(05)80853-3
Haimov, 1995, Melatonin replacement therapy of elderly insomniacs, Sleep, 18, 598, 10.1093/sleep/18.7.598
Hirata, 1974, In vitro and in vivo formation of two new metabolites of melatonin, J Biol Chem, 249, 1311, 10.1016/S0021-9258(19)42976-1
Hunt, 2001, Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock, Am J Physiol Cell Physiol, 280, C110, 10.1152/ajpcell.2001.280.1.C110
Karasek, 2002, Expression of melatonin MT(1) and MT(2) receptors, and ROR alpha(1) receptor in transplantable murine Colon 38 cancer, Neuro Endocrinol Lett, 23, 55
Kennaway, 1988, Structure-activity studies of melatonin analogues in prepubertal male rats, Aust J Biol Sci, 41, 393, 10.1071/BI9880393
Kennedy, 2005, Sexual function in remitted depressed patients following agomelatine and venlafaxine XR treatment, J Eur Coll Neuropsychopharmacol, 15, S440, 10.1016/S0924-977X(05)80900-9
Klein, 1999, Serotonin N-acetyltransferase. A personal historical perspective, Adv Exp Med Biol, 460, 5, 10.1007/0-306-46814-X_2
Kopp, 1999, The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H/He mice, Behav Pharmacol, 10, 73, 10.1097/00008877-199902000-00007
Kräuchi, 1997, Early evening melatonin and S-20098 advance circadian phase and nocturnal regulation of core body temperature, Am J Physiol, 272, R1178
Kräuchi, 2000, Functional link between distal vasodilation and sleep-onset latency?, Am J Physiol Regul Integr Comp Physiol, 278, R741, 10.1152/ajpregu.2000.278.3.R741
Krause, 1999, Melatonin and cardiovascular function, Adv Exp Med Biol, 460, 299, 10.1007/0-306-46814-X_32
Le Gouic, 1996, Effects of both a melatonin agonist and antagonist on seasonal changes in body mass and energy intake in the garden dormouse, Int J Obes Relat Metab Disord, 20, 661
Leger, 2004, Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy, Am J Med, 116, 91, 10.1016/j.amjmed.2003.07.017
Lôo, 2003, [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin-agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders.], Encephale, 29, 165
Martin, 1980, Melatonin inhibition of the in vivo pituitary response to luteinizing hormone-releasing hormone in the neonatal rat, Neuroendocrinology, 31, 13, 10.1159/000123044
Masana, 2000, Circadian rhythm of mt1 melatonin receptor expression in the suprachiasmatic nucleus of the C3H/HeN mouse, J Pineal Res, 28, 185, 10.1034/j.1600-079X.2001.280309.x
Meier, 1988, [Benzodiazepine–practice and problems of its use.], Schweizerische medizinische Wochenschrift, 118, 381
Mills, 1992, Genetic and physical mapping on chromosome 4 narrows the localization of the gene for facioscapulohumeral muscular dystrophy (FSHD), Am J Hum Genet, 51, 432
Miyamoto, 2004, The sleep-promoting action of ramelteon (TAK-375) in freely moving cats, Sleep, 27, 1319, 10.1093/sleep/27.7.1319
Morin, 1997, Melatonin high-affinity binding to alpha-1-acid glycoprotein in human serum, Pharmacology, 54, 271, 10.1159/000139495
Mulchahey, 2004, A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog beta-methyl-6-chloromelatonin, Life Sci, 75, 1843, 10.1016/j.lfs.2004.03.023
Nelson, 1995, Physiological roles and properties of potassium channels in arterial smooth muscle, Am J Physiol, 268, C799, 10.1152/ajpcell.1995.268.4.C799
Noda, 1994, The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines, J Biol Chem, 269, 6743, 10.1016/S0021-9258(17)37438-0
Olcese J ed (1999) Melatonin after Four Decades: An Assessment of its Potential, Kluwer Academic/Plenum Publishers, New York.
Ozaki, 1976, Presence of melatonin in plasma and urine or pinealectomized rats, Endocrinology, 99, 641, 10.1210/endo-99-2-641
Pawlikowski, 2002, Oncostatic action of melatonin: facts and question marks, Neuro Endocrinol Lett, 23, 24
Pitrosky, 1991, Effects of different doses and durations of melatonin infusions on plasma melatonin concentrations in pinealectomized Syrian hamsters: consequences at the level of sexual activity, J Pineal Res, 11, 149, 10.1111/j.1600-079X.1991.tb00471.x
Popova, 1995, Melatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slices, J Neurochem, 64, 130, 10.1046/j.1471-4159.1995.64010130.x
Quera-Salva, 2005, P. 2.102 Effect of agomelatine on the sleep EEG in patients with major depressive disorder (MMD), J Eur Coll Neuropsychopharmacol, 15, S435, 10.1016/S0924-977X(05)80891-0
Racagni, 2007, The interaction between the internal clock and antidepressant efficacy, Int Clin Psychopharmacol, 22, S9, 10.1097/01.yic.0000277957.75852.c7
Régrigny, 1998, Melatonin improves cerebral circulation security margin in rats, Am J Physiol, 275, H139
Rönnberg, 1990, Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration, J Clin Endocrinol Metab, 71, 492, 10.1210/jcem-71-2-493
Ruffolo R Humphrey P Watson S Spedding M (2000) Revised NC-IUPHAR recommendations for nomenclature of receptors, in The IUPHAR Compendium of Receptor Characterization and Classification ( Ruffolo R ed) pp 7–8, IUPHAR Media, London, UK.
Schaeffer, 1995, Melatonin and serotonin directly regulate oxytocin, insulin-like growth factor-I and progesterone secretion by cultured human granulosa cells, Adv Exp Med Biol, 395, 547
Scher, 2002, MT(1) melatonin receptor in the human retina: expression and localization, Invest Ophthalmol Vis Sci, 43, 889
Song, 1997, Studies of the renal action of melatonin: evidence that the effects are mediated by 37 kDa receptors of the Mel1a subtype localized primarily to the basolateral membrane of the proximal tubule, FASEB J, 11, 93, 10.1096/fasebj.11.1.9034171
Strader, 1989, Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor, J Biol Chem, 264, 13572, 10.1016/S0021-9258(18)80035-7
Sugden, 1995, Structural requirements at the melatonin receptor, Br J Pharmacol, 114, 618, 10.1111/j.1476-5381.1995.tb17184.x
Sugden, 1994, 2-Iodo-N-butanoyl-5-methoxytryptamine: a potent melatonin receptro agonist, Pharmacol Commun, 4, 267
Sumaya, 2005, The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors, J Pineal Res, 39, 170, 10.1111/j.1600-079X.2005.00233.x
Vanecek, 1998, Cellular mechanisms of melatonin action, Physiol Rev, 78, 687, 10.1152/physrev.1998.78.3.687
Vanecek, 1995, Melatonin inhibition of GnRH-induced LH release from neonatal rat gonadotroph: involvement of Ca2+ not cAMP, Am J Physiol, 269, E85
Vanhoutte, 1996, X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes, Pharmacol Rev, 48, 1
Viswanathan, 1997, Melatonin receptors mediate contraction of a rat cerebral artery, Neuroreport, 8, 3847, 10.1097/00001756-199712220-00002
Witt-Enderby, 1996, Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells, Mol Pharmacol, 50, 166
Zemlan, 2005, The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial, J Clin Psychiatry, 66, 384, 10.4088/JCP.v66n0316